Alembic may give good return over next 2-3 years: Shahina Mukadam

Shahina Mukadam, Market Analyst, Varun Capital, talks to ET now on pharma stocks.

Shahina Mukadam, Market Analyst, Varun Capital, talks to ET now on pharma stocks.

You track the pharma space very closely give us a nice interesting midcap buzzing bet?

Well, I think if you really look in a small cap I would go with something like a Alembic it has got everything put together in terms of good land bank. It has got good products Glycodin, its restructuring its operations so I think Rs 40-Rs 42 stock.

So I think that could give you a good return over the next 2-3 years. Its like a dark horse and otherwise I would go with the steady stock like Biocon where you have everything going for it. I mean there is nothing absolutely that's going to happen overnight so you are going to get that huge 100% but yes if you hold it for the next 5 odd years you really slow and steady wins the race.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Related Companies

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Alembic may give good return over next 2-3 years: Shahina Mukadam
Text Size:AAA
Success
This article has been saved

*

+